Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Revue Neurologique|May 10, 2016
Alpha-synuclein-based models of Parkinson's diseaseB Dehay, P-O FernagutCell Death and Differentiation|August 4, 2012
Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiencyD Ramonet, C Perier, A Recasens, et al.Gene Therapy|August 31, 2017
In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's diseaseL Chansel-Debordeaux, M Bourdenx, S Dovero, et al.NPJ Parkinson'S Disease|December 31, 2024
Intracellular α-synuclein assemblies are sufficient to alter nanoscale diffusion in the striatal extracellular spaceJ Estaun-Panzano, S Nandi, Q Gresil, et al.Human Gene Therapy|September 1, 2011
Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cellsA Sánchez-Danés, A Consiglio, Y Richaud, et al.Science Advances|June 18, 2025
Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primatesR Kinet, M Bourdenx, S Dovero, et al.Science Advances|May 20, 2020
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primatesM Bourdenx, A Nioche, S Dovero, et al.Pageof 1